This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://dx.doi.org/10.1111/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q90828461
rdf:type
wikibase:Item
schema:description
im Februar 2019 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel scientific article published on 17 February 2019 наукова стаття, опублікована в лютому 2019 artículu científicu espublizáu en febreru de 2019
p:P577
wds:Q90828461-809CBADB-1B1F-4B18-BE2B-8EBC18FF1919
wdt:P577
2019-02-17T00:00:00Z
p:P2093
wds:Q90828461-1CB823CF-214B-477D-A42F-68115D0E20A3 wds:Q90828461-F3FCF078-ECBA-4929-9A2A-3A9B22D50B90
wdt:P2093
Raymond T Chung Xuan Deng
rdfs:label
The immunity-related GTPase M rs13361189 variant does not increase the risk for prevalent or incident steatosis; results from the Framingham Heart Study The immunity-related GTPase M rs13361189 variant does not increase the risk for prevalent or incident steatosis; results from the Framingham Heart Study
skos:prefLabel
The immunity-related GTPase M rs13361189 variant does not increase the risk for prevalent or incident steatosis; results from the Framingham Heart Study The immunity-related GTPase M rs13361189 variant does not increase the risk for prevalent or incident steatosis; results from the Framingham Heart Study
schema:name
The immunity-related GTPase M rs13361189 variant does not increase the risk for prevalent or incident steatosis; results from the Framingham Heart Study The immunity-related GTPase M rs13361189 variant does not increase the risk for prevalent or incident steatosis; results from the Framingham Heart Study
p:P50
wds:Q90828461-324A39FA-ED3A-4315-A9C0-4FE09AB32896 wds:Q90828461-C8F3D484-ABDB-4D44-ACEE-1905617F96E1 wds:Q90828461-5BC2DE0E-4F3C-4037-8F1E-64773382CF36
wdt:P50
wd:Q90828456 wd:Q56997374 wd:Q57045534
p:P1476
wds:Q90828461-3779823F-7765-4C84-A219-93789F0ED726
wdt:P1476
The immunity-related GTPase M rs13361189 variant does not increase the risk for prevalent or incident steatosis; results from the Framingham Heart Study
p:P304
wds:Q90828461-6292647F-94B7-41DF-923B-BF78D7B6E94C
wdt:P304
1022-1026
p:P31
wds:Q90828461-7297DFF1-0042-4507-8964-CBD9FCB309C3
wdt:P31
wd:Q13442814
p:P921
wds:Q90828461-E30B8D47-5EA7-40BA-B9D2-E505C12B30A6
wdt:P921
wd:Q1365091
p:P698
wds:Q90828461-19149B68-2E1F-45A7-BF3B-A50F93B5FAC1
wdtn:P698
n12:30597691
wdt:P698
30597691
p:P1433
wds:Q90828461-9807C386-9897-49AA-8DDB-7B9FF9D7B36D
wdt:P1433
wd:Q15765078
p:P433
wds:Q90828461-6443186A-91AF-4FF2-8003-7B1CA37E858C
p:P478
wds:Q90828461-A1271327-1028-4AE7-964C-16B682DAE79A
wdt:P433
6
wdt:P478
39
p:P356
wds:Q90828461-9C622EC3-79B5-46A1-AAFB-C66472C779D0
wdtn:P356
n11:LIV.14039
wdt:P356
10.1111/LIV.14039